INS and Nephropathy: Despite continuing innovation in blood glucose monitoring for insulin replacement therapy for T1D, suboptimal regulation of blood glucose levels persists as the cause of the chronic debilitating complications (e.g. retinopathies, nephropathies, heart disease) faced by T1D patients.